Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. | Drug Discov Today;13(7-8): 325-32, 2008 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.

Goddard, Andrew W; Shekhar, Anantha; Whiteman, Aaron F; McDougle, Christopher J.

Affiliation

Goddard AW; Department of Psychiatry, Indiana University School of Medicine, University Hospital, UH3124, 550 North University Boulevard, Indianapolis, IN 46202, United States. agoddard@iupui.edu

Drug Discov Today ; 13(7-8): 325-32, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18405845

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Anxiety Agents / Serotonin / Selective Serotonin Reuptake Inhibitors / Obsessive-Compulsive Disorder Limits: Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Anxiety Agents / Serotonin / Selective Serotonin Reuptake Inhibitors / Obsessive-Compulsive Disorder Limits: Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: Country of publication: